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Introduction
Serratia marcescens is a gram-negative bacillus, belonging 
to the family Enterobacteriaceae. This opportunistic 
human pathogen may cause various infections ranging 
from urinary and respiratory tract infection, wound 
infection, endocarditis, meningitis, to conjunctivitis 
pneumonia, and may even lead to septicemia.1,2 This 
pathogen is naturally present in soil and water, and 
accounts for about 1%-2% of the nosocomial infections 
and outbreaks occurring in intensive care units (ICUs), 
surgery units, medical wards, and neonatal ICUs.3 A 
recent study reported that S. marcescens is the third most 
common pathogen involved in neonatal ICU outbreaks.4 
The overall rates of mortality due to S. marcescens vary 
from 25%-58%.5,6 The drug resistance of S. marcescens 
to a broad spectrum of antibiotics complicates treatment 
and infection control in hospitals.7 Recently, the World 
Health Organization (WHO) listed S. marcescens as one 
among the top ten global priority pathogens with multiple 
drug-resistance.8,9 The complete genome sequence of S. 
marcescens strain ATCC 13880 was sequenced in 2014 
and the total genome assembly constitutes 5 131 448 
bp long including 4724 protein coding sequences.10 
Advances in high throughput technologies, such as 
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Introduction: Serratia marcescens, an 
opportunistic human pathogen, is reported as 
an important cause of nosocomial infection and 
outbreaks. Although the genome of S. marcescens 
(ATCC 13880) was completely sequenced by 
2014, there are no studies on the proteomic 
profile of the organism.  The objective of the 
present study is to analyze the protein profile of S. 
marcescens (ATCC 13880) using a high resolution 
mass spectrometry (MS).
Methods: Serratia marcescens ATCC 13880 strain 
was grown in Luria-Bertani broth and the protein 
extracted was subjected to trypsin digestion, followed by basic reverse phase liquid chromatography 
fractionation. The peptide fractions were then analysed using Orbitrap Fusion Mass Spectrometry and 
the raw MS data were processed in Proteome Discoverer software. 
Results: The proteomic analysis identified 15 009 unique peptides mapping to 2541 unique protein 
groups, which corresponds to approximately 54% of the computationally predicted protein-coding 
genes. Bioinformatic analysis of these identified proteins showed their involvement in biological 
processes such as cell wall organization, chaperone-mediated protein folding and ATP binding. 
Pathway analysis revealed that some of these proteins are associated with bacterial chemotaxis and 
beta-lactam resistance pathway. 
Conclusion: To the best of our knowledge, this is the first high-throughput proteomics study of S. 
marcescens (ATCC 13880). These novel observations provide a crucial baseline molecular profile of 
the S. marcescens proteome which will prove to be helpful for the future research in understanding the 
host-pathogen interactions during infection, elucidating the mechanism of multidrug resistance, and 
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w/ Probe (Marshall Scientific, Hampton, NH, USA), 
Speed VacTM SPD1010 system (Thermo Fisher Scientific, 
Bremen, Germany), Agilent 1100 series HPLC system 
(Agilent, Santa Clara, CA, USA), Orbitrap Fusion Tribrid 
mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany), Eppendorf Centrifuge 5424 R (Eppendorf, 
Hamburg, Germany), Eppendorf ThermoMixer C 
(Eppendorf, Hamburg, Germany) were applied.
Preparation of Serratia marcescens culture
Serratia marcescens strain was purchased from American 
Type Culture Collection (ATCC number 13880) and was 
grown on LB agar plates (37°C overnight). The LB liquid 
medium was prepared in 500 mL Erlenmeyer flask. Then, 
colonies from the LB plate were picked and inoculated in 
500 mL Erlenmeyer flask and incubated for 18-24 hours 
at 37°C with shaking (300 RPM). The final concentration 
of the bacterial suspension was adjusted to 0.5 McFarland 
standards (~1.5 x 108 CFU/mL at 600 nm wavelength) and 
then bacterial suspension was subjected to centrifugation 
for a period of 10 minutes at 1500 x g at 4°C. Further, these 
cell pellets were collected and washed four times with ice-
cold PBS and stored at −80°C.
Sample preparation and fractionation
The cell pellets with buffer containing 4% SDS were 
subjected to five cycles of sonication for 30 seconds 
and 20% amplitude with an interval of 5 seconds each 
in Branson 450 Digital Sonifier (Marshall Scientific, 
Hampton, NH, USA). The lysates were centrifuged at 
14 000 RPM for 10 minutes and the clear supernatant 
was collected and aliquoted. One aliquot was used for 
protein estimation using BCA assay and the other aliquot 
was stored at –80°C till further analysis. In-solution 
digestion and fractionation was performed as described 
previously.23,24 In brief, 500 µg of protein was subjected to 
reduction using 100 mM DTT and alkylation using 10 mM 
IAA, followed by buffer exchange with 8 M urea to reduce 
the SDS concentration, using a 30 kDa MWCO spin filters 
(EMD Millipore, Billerica, MA). The buffer exchanged 
sample was diluted to bring down the concentration 
of urea to 2 M and proteins were then digested using 
sequencing grade modified trypsin (Promega, Madison, 
WI. Cat #: V5111) overnight at 37°C. 
The peptide digest was cleaned using Sep-Pak C18 
columns using two solvents; solvent A - 0.1% formic acid 
and solvent B - 40% ACN, 0.1% formic acid. Briefly, the 
Sep-Pack C18 column was activated by passing 5 mL of 
100% ACN, and then equilibrated the column twice with 
5 mL of 0.1% formic acid. The sample was reconstituted 
in 5 mL of 0.1% formic acid and loaded onto the Sep-Pack 
C18 column. The first flow through was collected and re-
loaded onto the column and then, the column was washed 
twice with 5 mL of 0.1% formic acid. Peptides were eluted 
by passing 3 mL of 40% ACN, 0.1% formic acid and the 
eluate was collected in fresh Falcon 15 mL tube (This step 
proteomics, is emerging as an alternative strategy to 
address the multidrug resistance by understanding the 
mechanisms involved in drug resistance.11,12 Proteomics 
can offer multiple advantages by the identification and 
characterization of novel proteins which are directly or 
indirectly involved in drug resistance that could be used 
as potential targets in future.13-15 
In the last two decades, mass spectrometry (MS)-
based proteomics has been effectively used to study 
proteome of microorganism, protein-protein interactions, 
differentially expressed proteins in order to better 
understand the molecular mechanism of microbial 
pathogenesis,16 and antibiotic resistance mechanisms.17 
Compared to other important gram-negative bacteria, 
there are limited proteomic studies on S. marcescens.18-22 
Despite the previous efforts in S. marcescens proteome 
characterization, there are no studies involving a detailed 
proteomic profiling of S. marcescens ATCC 13880 strain. 
In the present study, we have carried out a detailed 
proteome analysis of S. marcescens using high-resolution 
MS to provide the baseline data for future research. The 
study resulted in the identification of 2541 proteins, 
most of which were found to be associated with cell wall 
organization, chaperone-mediated protein folding, solute 
transport, signal transduction, ATP binding, metal ion 
binding, and protein transmembrane transporter activity. 
Proteins involved in important pathways including 
chemotaxis pathway, beta lactam resistance pathway, and 
bacterial secretion system pathway were also identified 
in the analysis. The information derived from this study 
could serve as a platform for future proteomic studies on 
the S. marcescens ATCC 13880. 
Materials and Methods 
Materials 
Sodium lauryl sulfate (SDS), dithiothreitol (DTT), 
iodoacetamide (IAA), formic acid, acetonitrile (ACN), 
triethylammonium bicarbonate (TEABC) were supplied. 
All chemicals used were of analytical grade and were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). 
Luria-Bertani (LB) (HiMedia Laboratories Pvt. Ltd, 
Mumbai, India), Sequencing grade modified trypsin 
(Promega, Madison, WI, USA), Bicinchoninic acid assay 
(BCA) (Thermo Fisher Scientific, Rockford, IL, USA). J. 
T. Baker MS grade water (Fischer Scientific, Waltham, 
MA, USA), 30 kDa Molecular weight cutoff (MWCO) 
spin filters (EMD Millipore, Billerica, MA, USA), Sep-Pak 
C18 columns (Waters Corporation, Milford, MA, USA), 
XBridge C18, 5 µm 250 x 4.6 mm column (Waters, Milford, 
MA, USA), Trap column (75 µm x 2 cm) packed in-house 
with Magic C18 AQ (Michrom Bioresources, Inc., Auburn, 
CA, USA) were also purchased. 
Equipment
New Brunswick Scientific Incubator Shaker (IL Exella 
E24) (Edison, NJ, USA), Branson 450 Digital Sonifier 
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was repeated). The eluate containing cleaned peptides 
collected from Sep-Pak C18 columns was vacuum-dried 
using SAVANT SPD 1010 Speed Vac Concentrator as 
reported previously.25 The vacuum-dried samples were 
reconstituted in basic reverse phase liquid chromatography 
(bRPLC) solvent A containing 10 mM TEABC in water at 
pH 8.5 and loaded on XBridge C18, 5 µm 250 x 4.6 mm 
column connected to Agilent 1100 series HPLC system. 
The peptide digest was resolved using a gradient of 0 
to 40% solvent B containing 10 mM TEABC in ACN at 
pH 8.5 in 50 minutes. The total fractionation time was 
60 minutes. A total of 96 fractions were collected and 
concatenated to 6 fractions based on the hydrophobicity as 
reported earlier.26 These fractions were then vacuum dried 
and stored at -20°C until further LC-MS/MS analysis was 
performed. All buffers and reagents used in the study are 
provided in Supplementary file 1.
LC-MS/MS analysis
MS analysis was performed using the Orbitrap Fusion 
Tribrid mass spectrometer (Thermo Fisher Scientific, 
Bremen, Germany) coupled to an Easy-nLC-1200 
nanoflow LC system (Thermo Scientific). The peptide 
digests from each fraction were reconstituted in 20 µL of 
solvent A (0.1% formic acid in water) and around 10 µL of 
this sample having 2 µg of peptide was loaded onto trap 
column (75 µm x 2 cm) packed in-house with Magic C18 
AQ (Michrom Bioresources, Inc., Auburn, CA, USA, 5 µm 
particle size, pore size 100 Å) at a flow rate of 5 µL/min 
with solvent A (0.1% formic acid in water). The separation 
of peptides was performed on an analytical column (75 
µm x 15 cm) using a gradient of solvent A (0.1% formic 
acid) and solvent B (90% ACN with 0.1% formic acid) 
over 90 minutes at a flow rate of 300 nL/min. Six LC-MS/
MS runs were performed. Data-dependent MS acquisition 
in positive mode was achieved at a resolution of 120 000 
for the top ten precursor ions with a scan range of 350–
1600 m/z. For MS/MS, top intense precursor ions from 
a 3-second duty cycle were preferred and subjected to 
higher-energy collision dissociation with 32% normalized 
collision energy. The fragment ions were detected at 
a mass resolution of 15 000 at m/z of 200 as explained 
previously.23,27
Data analysis
The MS/MS searches were performed using SEQUEST 
(version 2.4.1) search algorithm through Proteome 
Discoverer (version 2.2) software (Thermo Scientific) 
against S. marcescens (ATCC 13880) NCBI protein list 
(https://www.ncbi.nlm.nih.gov/). The search database 
was created by downloading all the proteins using 
“Serratia marcescens subsp. marcescens ATCC 13880” 
as search key words from NCBI. The search workflow 
included SEQUEST (version 2.4.1), spectrum selector, 
search nodes, spectrum files, Sequest HT, and Percolator. 
Carbamidomethylation of cysteine was set as a fixed 
modification, acetylation of protein N-termini, and 
oxidation of methionine, and deamidation of asparagine 
and glutamine was set as a variable modification. MS 
and MS/MS mass tolerances were set to 10 ppm and 
0.02 Da, respectively. The data was searched against 
the decoy database, and 1% false discovery rate (FDR) 
at both peptides and peptide spectral match levels was 
applied for the analysis.28 The Bioinformatics analysis of 
the proteomic data obtained in this study was performed 
using PANTHER (http://www.pantherdb.org/),29 DAVID 
(V. 6.8),30,31 STRING (V. 11.0) (https://string-db.org/),32 
and KEGG Pathway (http://www. genome.ad.jp/kegg/).33 
Data availability 
Raw MS files obtained in this experiment have been 
uploaded to the ProteomeXchange Consortium (http://
proteomecentral.proteomexchange.org),34 through the 
PRIDE partner repository with the dataset identifier 
PXD011776. 
Results 
Proteomic analysis of S. marcescens (ATCC 13880)
The objective of the present study was to perform 
proteomic profiling to make a comprehensive proteome 
map of S. marcescens (ATCC 13880). Overview of 
the proteomic workflow to study the proteome of S. 
marcescens is shown in Fig. 1. Organism grown in LB 
medium post sonication extraction yielded ~8 mg/mL 
protein. Around 500 µg of the protein was subjected to 
in-solution digestion. Digested peptides were fractionated 
using bRPLC and these fractionated peptides were 
concatenated to 6 fractions and analyzed on LC-MS/MS. 
The analysis of these fractions resulted in the acquisition of 
130448 MS/MS spectra, and the database searches against 
S. marcescens (ATCC 13880) NCBI protein database using 
SEQUEST resulted in the identification of 16 306 peptide-
spectrum matches. A total of 15 009 unique peptides 
were identified (1% FDR), which mapped to 2541 protein 
groups accounting for 54% of the S. marcescens (ATCC 
13880) proteome. The identified proteins and peptides 
Fig. 1. Overview of the proteomic workflow applied to study the proteome 
of S. marcescens: S. marcescens ATCC 13880 was cultured, protein was 
isolated from cell pellets and digested using trypsin enzyme. The digest 
was fractionated using bRPLC, acquired data on mass spectrometry and 
analyzed the data using Bioinformatics approach.
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are given in Tables S1 and S2 (see Supplementary files 
2 and 3). The majority (78%) of the reported proteins 
were identified based on two or more unique peptides. 
On average, 6 unique peptides were found for each of 
the identified proteins. Representative mass spectra are 
shown in Supplementary file 4.
Gene Ontology analysis
The selected list of proteins was analysed for their gene 
ontology (GO) using PANTHER classification system. 
The identified proteins were classified as those involved in 
biological processes, molecular functions, and according 
to their cellular localization (Fig. 2 and Table 1). With 
reference to the biological process, majority of the 
proteins (31%) were involved in binding, 24% in catalytic 
activity, 16% molecular transduction activity, another 16% 
in transcription regulator activity, and 13% in transporter 
activity.
Functional enrichment analysis of the identified proteins
The identified proteins were further categorized into 
different classes by sorting them based on their names 
manually. These classes include molecular chaperone 
proteins, outer membrane proteins, two-component 
systems proteins, and type VI secretion system proteins. 
Protein network and pathway analysis
To understand the biological network complex involved, 
STRING analysis was performed.32 The analysis showed 
protein–protein interaction networks that are associated 
with protein export, cellular localization, bacterial 
secretion, protein insertion into membrane, membrane 
organization, and signal transductions. The detailed 
interactions of these networks are given in Fig. 3. Pathway 
analysis of the S. marcescens proteomic data resulted in 
the identification of two component systems pathway, 
chemotaxis pathway (Fig. 4), beta-lactam resistance 
pathway (Fig. 5), and bacterial secretion system pathways 
(Table 2).
Discussion
The sequencing of bacterial genome has contributed a 
lot to elucidating various aspects of bacterial infection. 
However, a major obstruct in utilizing the bacterial 
genomic sequence for the study of pathogenesis is the 
fact that there are many parts of the genes with unknown 
function in each organism sequenced to date.35 Hence, 
a detailed proteomic profiling of such organisms are 
important to draw conclusions on the host-pathogen 
interaction during an infection. Recent advances in MS 
instrumentation and the application of these sensitive 
high-throughput analytical instruments to study the 
proteins is opening new perspectives in microbiology.36 
In the last two decades much attention has been paid 
to study the proteome of different human pathogenic 
bacteria.37,38 S. marcescens is one of the pathogenic bacteria 
and many strains of this bacterium have been sequenced 
at genome and proteome levels.10,18,20,22,39-41 To the best 
of our knowledge, the genome of S. marcescens (ATCC 
13880) sequence is available and the proteome of the same 
is not available till date.10 Hence, this study was performed 
to understand the proteome of S. marcescens (ATCC 
13880). This strain was initially isolated from pond water 
and later known to be pathogenic to humans especially 
children and the immunocompromised patients in the 
ICU units.42,43 This is the first detailed proteomic analysis 
for S. marcescens (ATCC 13880) in which we were able 
to identify 2541 protein groups accounting for 54% of the 
S. marcescens (ATCC 13880) proteome. In this study, we 
reported the identification of important class of proteins 
which are essential for the growth and function of S. 
marcescens including molecular chaperone proteins, outer 
membrane proteins, two-component system proteins and 
type VI secretion system proteins. Different studies have 
shown that these classes of proteins play an important role 
in the physiology and virulence of S. marcescens.44-49 
Analysis of molecular chaperone proteins
In this study, we identified 21 molecular chaperone 
proteins and analysis of these proteins showed that they 
are mainly involved in cell wall organization, chaperone-
mediated protein folding and response to heat. Further, 
Fig. 2. Gene Ontology analysis: A histogram depicting the distribution of 
Serratia marcescens proteins among various (A) biological processes and 
(B) molecular functions and (C) subcellular localizations.
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Table 1. Functional analysis of the proteins identified in the study
Description Molecular function Biological processes Cellular localization Domain
Molecular chaperone proteins identified
Hsp33 family molecular 
chaperone HslO Unfolded protein binding Protein folding Cytoplasm Redox-active center
Chaperone protein papD Chaperone












Chaperone protein FimB Chaperone





Chaperone protein YcdY Chaperone Bacterial-type flagellum-dependent swarming motility  Cytosol Coiled coil
Chaperone protein fimC Chaperone





Molecular chaperone DnaJ Unfolded protein binding Protein folding, response to heat Cytoplasm Repeat, Zinc-finger
Molecular chaperone DnaK Unfolded protein binding Protein folding, response to heat Cytoplasm Repeat, Zinc-finger
Molecular chaperone HtpG Unfolded protein binding Protein folding Cytoplasm  Unknown
Molecular chaperone OsmY Unknown Unknown Unknown Unknown
Molecular chaperone Skp Unfolded protein binding Signaling Outer membrane-bounded periplasmic space Coiled coil
Chaperonin GroEL Unfolded protein binding Protein refolding Cytoplasm Coiled coil
ATP-dependent chaperone 
ClpB Unfolded protein binding Protein folding Cytoplasm Coiled coil
Molecular chaperone HtpG Unfolded protein binding Protein folding Cytoplasm Coiled coil
Co-chaperone YbbN  Unknown Cell redox homeostasis Cell Thioredoxin
Fe-S protein assembly 
chaperone HscA Unknown Unknown Unknown Unknown
Heat shock chaperone IbpB Chaperone Protein stabilization Cytoplasm  Unknown
Co-chaperone GroES Unknown Unknown Unknown Unknown
Co-chaperone DjlA Chaperone binding Signaling Integral component of membrane  Transmembrane
Co-chaperone HscB ATPase activator activity Protein complex oligomerization, protein folding  Unknown Coiled coil
Chaperone-modulator protein 
CbpM Unknown Unknown  Unknown Coiled coil
Outer membrane proteins
Outer membrane protein A Porin activity Conjugation, ion transport Cell outer membrane Signal
Outer membrane assembly 
protein AsmA Unknown 
Regulation of protein targeting 





endopeptidase activity Unknown Outer membrane
Coiled coil
Outer membrane channel 
protein TolC 
Efflux transmembrane 
transporter activity Unknown Outer membrane Signal
Outer membrane lipid 
asymmetry maintenance 
protein MlaD 
Unknown Phospholipid transport Integral component of membrane Transmembrane,
Outer membrane lipoprotein 
chaperone LolA 
Lipoprotein transporter 
activity Protein transport Periplasmic space Signal
Outer membrane protein 
assembly factor Unknown 
Gram-negative-bacterium-type 
cell outer membrane assembly Cell outer membrane Signal
Outer membrane protein 
assembly factor BamA Unknown 
Gram-negative-bacterium-type 
cell outer membrane assembly Cell outer membrane Repeat
Gangadharappa et al
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Outer membrane protein 
assembly factor BamB Unknown 
Gram-negative-bacterium-type 
cell outer membrane assembly Cell outer membrane Signal 
Outer membrane protein 
assembly factor BamC Unknown 
Gram-negative-bacterium-type 
cell outer membrane assembly Cell outer membrane Signal
Outer membrane protein 
assembly factor BamD Unknown 
Gram-negative-bacterium-type 
cell outer membrane assembly Cell outer membrane Signal
Outer membrane protein 
assembly factor BamE Unknown 
Gram-negative-bacterium-type 
cell outer membrane assembly Cell outer membrane Signal
Outer membrane protein 
OmpW Unknown Transmembrane transport Cell outer membrane Signal
Outer membrane protein 
OmpX Identical protein binding
Protein insertion into 
membrane from inner side
Outer membrane-bounded 
periplasmic space Signal
Outer membrane usher protein Fimbrial usher porin activity Pilus assembly Cell outer membrane Transmembrane
Two component systems proteins
Two-component sensor 
histidine kinase BarA 
Phosphorelay sensor 
kinase activity Unknown 
Integral component of 
membrane Transmembrane
Two-component system QseEF-
associated lipoprotein QseG  Unknown Unknown  Unknown Coiled coil
Two-component system 
response regulator ArcA DNA binding
Phosphorelay signal 
transduction system Unknown Unknown 
Two-component system 
response regulator BaeR 
DNA-binding transcription 
factor activity Regulation of response to drug Cytosol Coiled coil
Two-component system 
response regulator BasR DNA binding
Phosphorelay signal 
transduction system Unknown Unknown 
Two-component system 
response regulator CreB DNA binding
Phosphorelay signal 
transduction system Unknown Unknown 
Two-component system 
response regulator DcuR ATP binding Regulation of response to drug
Integral component of 
membrane Transmembrane
Two-component system 
response regulator GlrR DNA binding
Phosphorelay signal 
transduction system Unknown Unknown 
Two-component system 
response regulator NarL DNA binding
Phosphorelay signal 
transduction system Unknown Unknown 
Two-component system 




transduction system Cytosol  Unknown
Two-component system 




transduction system Cytosol Unknown 
Two-component system 




transduction system Cytosol Unknown 
Two-component system 
response regulator UvrY DNA binding
Phosphorelay signal 
transduction system Cytoplasm Unknown 
Two-component system 
response regulator YehT DNA binding
Phosphorelay signal 
transduction system  Cell inner membrane Unknown 
Two-component system sensor 
histidine kinase CpxA ATP binding
Signal transduction by protein 
phosphorylation
Integral component of 
membrane Unknown 
Two-component system sensor 
histidine kinase DcuS ATP binding
Phosphorelay signal 
transduction system
Integral component of 
membrane Transmembrane
Two-component system sensor 
histidine kinase EnvZ ATP binding
Phosphorelay signal 
transduction system
Integral component of 
membrane Transmembrane
Two-component system sensor 
histidine kinase PhoQ ATP binding
Phosphorelay signal 
transduction system
Integral component of 
membrane Transmembrane
Two-component system sensor 
histidine kinase PhoR ATP binding
Cellular response to phosphate 
starvation
Integral component of 
membrane Transmembrane
Two-component system sensor 
histidine kinase QseC ATP binding
Cellular response to phosphate 
starvation
Integral component of 
membrane Transmembrane
Two-component system sensor 
histidine kinase RcsC ATP binding
Cellular response to phosphate 
starvation
Integral component of 
membrane Transmembrane
Description Molecular function Biological processes Cellular localization Domain
Molecular chaperone proteins identified
Table 1. Continued 
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we found that most of them are located in cytoplasm and 
outer membrane-bounded periplasmic space having coiled 
coil or signal domain. These classes of proteins include 
17 KD protein Skp and molecular chaperone protein 
dnaK (DnaK). Molecular chaperone 17 KD protein Skp 
is a trimeric periplasmic 17 KD protein that helps outer 
membrane proteins in their folding and incorporation into 
membranes.50 Skp is a significantly important protein in 
the chaperone system which has been distinguished for its 
function in outer membrane protein (OMP) biogenesis,51 
where it interacts with unfolded proteins.52 Skp assists 
in releasing the translocated proteins from the plasma 
membrane and corrects folding of numerous OMPs.53,54 
However, the molecular mechanisms of how Skp performs 
its chaperone role have remained unclear,55,56 and it 
has been also reported that it does not show sequence 
similarity to any other chaperone.50
The protein DnaK, another important protein in the 
category, is a heat shock protein 70 (hsp70) which is a 
member of the molecular chaperones family. Studies show 
that hsp70s are essential part of the cell’s protein folding, 
degradation and repair machinery.57 DnaK proteins coat 
polypeptide chains as they come out from membranes 
or ribosomes, averting accumulation reactions and 
premature folding.58 DnaK helps cell to prevent 
denaturation of proteins and support the deprivation of 
the damaged proteins during stress conditions and play 
a vital role in chromosomal DNA replication (Table 1).18 
Fig. 3. Interaction network analysis: STRING interaction network depicts the association among the proteins. Color balls are representing individual protein. 
Red: involved in beta-lactam resistance. Green: Bacterial secretion system, Blue: Bacterial chemotaxis and Yellow: Two-component systems.
Fig. 4. Pathway map representation of identified proteins involved in bacterial chemotaxis pathway.
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Analysis of outer membrane proteins 
The outer membrane of gram-negative bacteria plays 
a role in membrane permeability and avoid the entry 
of toxic compounds and allow the influx of nutrient 
molecules.59 OMPs perform multiple functions including 
solute transport, membrane structure, signal transduction, 
stability and catalysis.60 In this study, we found 15 such 
outer membrane proteins. Functional analysis of the 
important proteins of this class includes outer membrane 
protein A (OmpA) and Outer membrane protein X 
(OmpX).
The OmpA belongs to the family of OMPs and it 
is conserved among gram-negative bacteria.61 OmpA 
proteins have been reported to play important pathogenic 
roles such as adhesion to mucosal surfaces, intracellular 
survival or invasion, stimulators of proinflammatory 
cytokine production, and antimicrobial peptide 
resistance.62 In S. marcescens, OmpA is an outer 
membrane protein with porin activity and conjugation or 
ion transport processes. The OmpA has been reported to 
play structural and ion-permeable porin roles which help 
in bacterial survival during osmotic stress conditions.63
OmpX proteins are small molecular weight (15 to 18 
KD) proteins and belong to a family of conserved bacterial 
proteins where they support adhesion to and entry into 
mammalian cells.64, 65 These proteins fold in an eight-beta-
barrel structure through membrane-spanning domains 
that project from the cell surface.66 OmpX are involved 
in physiological processes such as antibiotic resistance, 
invasion, signal transduction, internalization in epithelial 
cells, binding external proteins, contributing to channeling 
and virulence.64, 67-69 
Analysis of two-component system proteins
The ability to sense and respond to its surroundings 
is fundamental to the survival of a bacterium. Two-
component regulatory systems are reported as key 
mechanism through which bacteria perceive and respond 
to their environment.70, 71 Two component system proteins 
have been studied to be associated with physiological 
functions including competence, antibiotic resistance, 
cell-cell communication, adaptation to environments, 
and sporulation.72 In this study we reported 22 such 
two-component system proteins. PhoP/PhoQ system is 
one among the 22 component system proteins reported 
in this study. It is a two-component system that controls 
the expression of genes associated with virulence, the 
adaptation to Mg2+ restrictive environments, and controls 
various cellular activities in numerous gram-negative 
species.73 Studies reported that in non-pathogenic 
bacteria PhoP/PhoQ system plays a role in the control 
of the magnesium homeostasis, whereas in pathogenic 
bacteria it plays an essential role in the expression of vital 
virulence phenotypes.74 It is also reported that activity of 
the PhoP/PhoQ system permits Serratia to survive scarce 
environmental Mg2+ availability, acidic pH, and the action 
of the cationic antimicrobial compound polymyxin B.75 
Analysis of type VI secretion system proteins 
Gram-negative bacteria have evolved several secretion 
systems to deliver toxins and proteins into target cell, 
which are essential for virulence and survival within hosts. 
Type VI secretion system is widely used by gram-negative 
bacteria and it functions as nano-machine which expands 
from cytoplasm to the outer membrane to inject effector 
proteins into target cells.76,77 T6SS is composed of at least 13 
Fig. 5. Pathway map representation of identified proteins involved in beta-lactam resistance pathway.
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core-component proteins and is associated with auxiliary 
component proteins.77 These core-component proteins 
are categorized into different subunits: the membrane 
complex (TssJLM), the baseplate complex (TssAEFGK), 
needle sheath complex (TssBC), sheath recycling ATPase 
(TssH), and the injection apparatus (Hcp, VgrG).78 In 
the present study we found 12 such core-component 
proteins (TssABC, Hcp1, TssFGH, VgrG, TssJKLM) and 
two additional auxiliary component proteins (TagH and 
TagF) (Table 2). Interestingly, most of these proteins 
found to be in the cytoplasmic region which suggests that 
these cytoplasm proteins can be further investigated for 
enhanced understanding of secreted protein transport 
during the pathogenesis.19 These proteins have been 
reported to play a role in various diseases.2,79
Protein network and pathway analysis
Proteins associated with bacterial chemotaxis pathway 
and beta lactam resistance pathway were identified by 
the proteomic profiling of S. marcescens chemotaxis, the 
capacity of gram-negative bacteria to move in response 
to external stimuli has long been concerned in the 
bacterial colonization and pathogenicity.80 In this study 
we identified 7 proteins which belong to chemotaxis 
pathway (Fig. 4). The prokaryotic chemotaxis pathway 
senses the external chemoeffector concentrations by the 
transmembrane receptor methyl-accepting chemotaxis 
protein (MCP).81 The binding of chemoeffector ligand 
to a chemoreceptor is signaled across the membrane 
to regulate the autophosphorylation activity of the 
CheA kinase with the help of an adaptor protein CheW. 
Once CheA is phosphorylated, the phosphoryl group is 
transferred to response regulator CheY. Phosphorylated 
CheY diffuses away from the signaling cluster and 
binds with the flagella motor switch proteins FliG, FliM 
and FliN to cause a change in the rotation direction 
of the motor. Interruption of any component of the 
chemotaxis signal transduction pathway (MCP receptor-
CheA/CheW-CheY-flagella cascade) reduces the ability 
of pathogens to colonize and cause disease.82 Drug 
resistant bacterial infections have significant impact 
on the morbidity and mortality, as a consequence of 
this WHO has raised serious concern to address the 
growing multidrug resistance in gram-negative bacteria.9 
Bacteria have developed several strategies of defense 
against classes of antibiotics, including elimination of 
antibiotics through efflux pumps, enzymatic inactivation 
of antibiotics (production of beta-lactamase enzymes) 
and expression of low affinity targets (penicillin-binding 
proteins).83 In this study we reported ten key proteins 
which belong to beta-lactam resistance pathway that may 
play an important role under these three strategies. TolC-
outer membrane channel protein and AcrAB-multidrug 
efflux pump transcriptional activator found to play a role 
in efflux pumps (RND family),84,85 AmpG- muropeptide 
transporter AmpG, nagZ-beta N-acetylhexosaminidase, 
AmpR- LysR family transcriptional regulator, SRT/
SST family class C beta-lactamase, and class B metallo-
beta-lactamases associated with enzymatic inactivation 
of antibiotics,86 whereas, carboxypeptidase/penicillin-
binding protein 1a, penicillin-binding protein 1b and 
penicillin-binding protein 2 play a role in the expression 
of low affinity targets.87,88 Further studies are essential 
to understand the detailed role of these proteins in drug 
resistance mechanism. 
Few studies have reported the proteomic analysis of 
this species, which helped in elucidating the molecular 
mechanisms underlying the resistance to, and removal 
of, some toxic elements such as manganese from the 
environment. Zakeri et al identified 130 proteins from 
Table 2. List of Type VI secretary proteins identified
Description Gene symbol T6SS subunit Domain 
Hcp1 family Type VI secretion system effector hcp1 Hcp1 Unknown
Type VI secretion system ATPase TssH clpV TssH Coiled coil
Type VI secretion system baseplate subunit TssF vasA TssF Unknown
Type VI secretion system baseplate subunit TssG tssG TssG Unknown
Type VI secretion system baseplate subunit TssK tssK TssK Unknown
Type VI secretion system contractile sheath large subunit tssC tssC Unknown
Type VI secretion system contractile sheath small subunit tssB tssB Unknown
Type VI secretion system lipoprotein TssJ tssJ TssJ Unknown
Type VI secretion system membrane subunit TssM icmF TssM Transmembrane
Type VI secretion system protein TssA tssA TssA Unknown
Type VI secretion system protein TssL tssL TssL Transmembrane
Type VI secretion system tip protein VgrG tssI VgrG Unknown
Type VI secretion system-associated FHA domain protein TagH tagH TagH Unknown
Type VI secretion system-associated protein TagF tagF TagF Unknown
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the strain ZF03 of S. marcescens under radium stress 
condition using MS/MS analysis.18 In another study 
Fritsch et al used LC-MS/MS to identify 842 proteins from 
the type VI secretion system (T6SS) dependent secretome 
of S. marcescens Db11 strain.19 Yi et al used 2D MALDI-
TOF MS analysis and reported 23 expressed proteins in S. 
marcescens ATCC 14041.20 Cianfanelli et al identified 1025 
proteins using LC-MS/MS based proteomic approach 
to measure the secretion of T6SS and VgrG dependent 
effector proteins in S. marcescens Db10 strain.21 Recently, 
Tuveng et al reported the identification of 232 secreted 
proteins from S. marcescens BJL200 strain.22 In one of the 
recent studies, Queiroz et al reported the alterations in the 
proteomic composition of S. marcescens in response to 
manganese (II).89 They performed the comparative study 
with the presence and absence of Mn (II). They reported 
the identification of structural proteins and enzymes 
related to major cellular and metabolic processes required 
for growth and survival of gram-negative bacteria. 
Additionally, they have shown the differential expression 
of these proteins in the absence and presence of Mn II. 
Through this study, they report the application of S. 
marcescens LG1 strain in bioremediation applications, in 
particular removal of Mn (II) from the drinking water and 
industrial water. 
The highlight of the present study is the use of high-
sensitive mass-spectrometry to report a large number of 
proteins in S. marcescens (ATCC 13880) which was not 
available earlier. We believe that the proteins reported in 
this study may be used to compare the proteomic changes 
in the stress-induced/disease conditions and other 
situations, which may help to draw the inferences on the 
role of this organism in antibiotic resistance. 
Conclusion
Serratia marcescens, one of the important human 
pathogens is ubiquitously distributed which causes 
nosocomial infections and outbreaks especially in children 
and immunocompromised patients. The situation is 
further worsened by the development of resistance to beta-
lactam antibiotics of S. marcescens. Recent advances and 
successful microbial proteomic experiments with MS-
based proteomics proves that MS can be used as a tool 
to understand the interaction between pathogens and 
their host such as that in infections and drug resistance. 
It involves the study of protein–protein interactions on 
a small and proteome-wide scale, defining proteome 
of several organelles, analysis of post-translational 
modifications, and quantitative estimation of change 
in the abundance of proteins. MS can be used to 
identify and quantify thousands of proteins in samples 
which have lots of applications in the field of clinical 
microbiology. LC-MS/MS-based proteomic studies will 
set the stage for the identification of proteins that are 
involved in virulence and pathogenesis of this organism 
and the host-pathogen interaction during infection. In the 
What is the current knowledge?
√ The complete genome sequence of S. marcescens strain 
ATCC13880 is available and computationally predicted to 
have 4724 protein coding sequences. 
√ Proteome of other strains of S. marcescens is available where 
as the whole proteome of S. marcescens ATCC 13880 remains 
largely unexplored.
What is new here?
√ The study provided experimental evidence at the level of 
protein expression for the computationally predicted gene 
annotations for the genome of S. marcescens strain ATCC 
13880.
√ The study provided the list of 2541 unique protein groups, 
which corresponds to ~54 % of the computationally predicted 
protein-coding genes with peptide level evidence and their 
associated Bioinformatics analysis.
√ The data and outcome of the study is valuable in addition to 
the microbial proteome project. 
Research Highlights
present study, we performed a detailed proteomic analysis 
of S. marcescens ATCC 13880, using MS-based advanced 
proteomic and bioinformatic approach to elucidate the 
proteome profile of S. marcescens ATCC 13880 which 
resulted in the identification of 2541 proteins. To the 
best of our knowledge, this study provides an in-depth 
coverage of the proteome and functional analysis of 
identified proteins. The study supplements the microbial 
proteome project and presents an essential knowledge of 
the S. marcescens ATCC 13880 proteome.
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